Cuba vs Mongolia: HIV-positive TB patients on ART (antiretroviral therapy)
Cuba
100.0%
in 2024
Mongolia
100.0%
in 2024
Cuba rank
1st
Mongolia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cuba
- Mongolia
How they compare
Cuba currently reports 100.0% against 100.0% in Mongolia, a difference of 0.0%.
The two have swapped places 8 times across 17 shared years of data; in 2006 it was Mongolia ahead.
Cuba ranks 1st and Mongolia ranks 1st of 144 countries.
Across the 3 decades both report, Cuba averaged higher in 1 and Mongolia in 2.
Head to head by decade
| Decade | Cuba | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 72.3% | 77.7% | 5.3% | Mongolia |
| 2010s | 88.0% | 78.1% | 9.9% | Cuba |
| 2020s | 98.8% | 100.0% | 1.2% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cuba or Mongolia?
- Cuba, at 100.0% against 100.0% in Mongolia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cuba and Mongolia?
- 0.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Mongolia?
- 17 years are reported by both, from 2006 to 2024.
- How do Cuba and Mongolia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cuba ranks 1st and Mongolia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.